Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes: An economic analysis

Diabetes Care

Volumn 28, Issue 6, 2005, Pages 1321-1325

  Zhang, Ping ^a   Engelgau, Michael M ^a   Valdez, Rodolfo ^a   Cadwell, Betsy ^a   Benjamin, Stephanie M ^a   Narayan, K M Venkat ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CAPILLARY BLOOD; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; SCREENING TEST;

BLOOD GLUCOSE; CAPILLARIES; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DIABETES MELLITUS; FASTING; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREDIABETIC STATE; SENSITIVITY AND SPECIFICITY; SOCIETIES, MEDICAL; UNITED STATES;

EID: 19944389279     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.6.1321     Document Type: Article

References (21)

1. Boyle JP, Honeycutt AA, Narayan KMV, Hoerger TJ, Geiss LS, Chen H, Thompson TJ: Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 24:1936-1940, 2001
2. World Health Organization. Report of a World Health Organization and International Diabetes Federation Meeting: Screening for Type 2 Diabetes. Geneva, World Health Org., 2003
3. American Diabetes Association: Screening for type 2 diabetes (Position Statement). Diabetes Care 27:S11-S14, 2004
4. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services: Report of the U.S. Preventive Services Task Force. Baltimore, MD, Williams & Wilkins, 2003
5. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, the Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
6. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA Jiang XG Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544, 1997
7. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072-2077, 2002
8. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
9. American Diabetes Association: The prevention or delay of type 2 diabetes (Position Statement). Diabetes Care 26:S62-S66, 2003
10. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study on behalf of the European Diabetes Epidemiology Group. Diabetologia 42:647-654, 1999
11. American Diabetes Association: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26:S5-S20, 2003
12. Bureau of the Census: Population Projections of the United States by Age, Race, and Hispanic Origin: 1995 to 2050. Washington, DC, U.S. Govt. Printing Office, 1996, p. 25-1130
13. National Center for Health Statistics: Third National Health and Nutrition Examination Survey, 1988-1994, Reference Manuals and Reports: Manual for Medical Technicians and Laboratory Procedures Used for NHANES III (CD-ROM). Hyattsville, MD, Centers for Disease Control and Prevention, 1996
14. Rolka DB, Narayan KMV, Thompson TJ, Goldman D, Lindenmayer J, Alich K, Bacall D, Benjamin EM, Lamb B, Stuart DO, Engelgau MM: Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care 24:1899-1903, 2001
15. Zhang P, Engelgau MM, Valdez R, Benjamin SM, Cadwell B, Venkat Narayan KM: Costs of screening for pre-diabetes among U.S. adults: a comparison of different screening strategies. Diabetes Care 26:2536-2542, 2003
16. HealthCare Consultants of America: Physicians Fee and Coding Guide. Augusta, GA, HealthCare Consultants of America, 2000
17. Garkovich L: Health and health care in rural America. Choice 9:8-12, 1994
18. US Office of Personnel Management: Privately owned vehicle mileage reimbursement rate [article online]. Available from http://www.opm.gov. Accessed 10 July 2001
19. Bureau of the Census: National compensation survey: occupational wages in the United States [article online]. Available from http://www.bls.gov/ncs/ocs/ home. htm. Accessed 20 July 2001
20. 1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 23:187-191, 2000
21. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BHR, Rutten G, ADDITION Study Group: The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Res 24:S6-S11, 2002